ArticleAlzheimer's & dementia (New York, N. Y.)2016

First in human study with a prodrug of galantamine: Improved benefit-risk ratio?

Anne C Baakman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.